Get the Stockscreener App
6.60
2.33%
0.17
Quanterix Corp stock is traded at $6.60, with a volume of 10,160.
It is up +2.33% in the last 24 hours and down -13.76% over the past month.
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.
See More
Previous Close:
$6.43
Open:
$6.42
24h Volume:
10,160
Relative Volume:
0.02
Market Cap:
$308.29M
Revenue:
$121.14M
Net Income/Loss:
$-32.33M
P/E Ratio:
-7.6744
EPS:
-0.86
Net Cash Flow:
$-22.69M
1W Performance:
+3.95%
1M Performance:
-13.76%
6M Performance:
-5.73%
1Y Performance:
-44.57%
1-Day Range:
$6.395
$6.60
1-Week Range:
$6.26
$6.70
52-Week Range:
$4.05
$12.21
Quanterix Corp Stock (QTRX) Company Profile
Name
Quanterix Corp
Sector
Industry
Phone
617-301-9400
Address
900 MIDDLESEX TURNPIKE, BILLERICA, MA
Compare QTRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QTRX
Quanterix Corp
|
6.60 | 300.35M | 121.14M | -32.33M | -22.69M | -0.86 |
|
ABT
Abbott Laboratories
|
128.85 | 219.88B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.69 | 141.54B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
357.50 | 133.39B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.06 | 124.82B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
86.07 | 48.84B | 5.88B | 1.34B | 799.60M | 2.3489 |
Quanterix Corp Stock (QTRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-11-25 | Downgrade | Canaccord Genuity | Buy → Hold |
| Feb-01-24 | Initiated | Scotiabank | Sector Outperform |
| Sep-25-23 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-08-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| May-23-23 | Upgrade | Goldman | Neutral → Buy |
| Aug-15-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-09-22 | Downgrade | Cowen | Outperform → Market Perform |
| Aug-09-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Mar-02-22 | Upgrade | Goldman | Sell → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-04-21 | Initiated | Goldman | Sell |
View All
Quanterix Corp Stock (QTRX) Latest News
Quanterix Corporation (NASDAQ:QTRX) Given Consensus Recommendation of “Hold” by Analysts - Defense World
Quanterix Stock: Can This High-Beta Diagnostics Play Turn Volatility Into Long-Term Alpha? - AD HOC NEWS
Quanterix (NASDAQ:QTRX) Raised to Hold at Wall Street Zen - Defense World
Quanterix assay helps shed light on Alzheimer’s prevalence - BioWorld MedTech
QTRX FinancialsIncome Statement - Quiver Quantitative
Quanterix (QTRX) Analyst Rating Update: Price Target Raised by C - GuruFocus
Quanterix (NASDAQ:QTRX) Given New $8.00 Price Target at Canaccord Genuity Group - MarketBeat
Quanterix (QTRX) Study Sheds Light on Alzheimer's Prevalence - GuruFocus
Quanterix Announces Landmark Nature Study Redefining Alzheimer’s Disease Neuropathology Prevalence - Yahoo Finance
Quanterix (NASDAQ:QTRX) Lowered to “Sell” Rating by Wall Street Zen - Defense World
Quanterix (NASDAQ:QTRX) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat
Is Quanterix Corporation stock attractive for income investorsPortfolio Gains Report & Real-Time Market Trend Scan - Улправда
Can Quanterix Corporation stock maintain growth trajectory2025 Breakouts & Breakdowns & Verified Short-Term Plans - Улправда
Alan Bruce Sachs Net Worth (2025) - GuruFocus
How sustainable is Quanterix Corporation stock dividend payoutPortfolio Update Report & Fast Exit/Entry Strategy Plans - DonanımHaber
Is Quanterix Corporation stock a top pick in earnings seasonWeekly Trend Recap & Weekly High Potential Stock Alerts - Улправда
Momentum Shift: Why Quanterix Corporation stock attracts high net worth investorsJuly 2025 Trends & Verified Swing Trading Watchlists - Улправда
Why Quanterix Corporation stock attracts high net worth investorsJuly 2025 Earnings & Safe Capital Allocation Plans - Улправда
CFO Sriram Acquires 548 Of Quanterix Corp [QTRX] - TradingView — Track All Markets
CEO Toloue Acquires 2,480 Of Quanterix Corp [QTRX] - TradingView — Track All Markets
Quanterix (QTRX) Projected to Post Earnings on Monday - MarketBeat
Quanterix (NASDAQ:QTRX) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat
Quanterix (NASDAQ:QTRX) Upgraded by Wall Street Zen to “Hold” Rating - Defense World
Quanterix Corporation (NASDAQ:QTRX) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Quanterix Corporation $QTRX Shares Purchased by Blue Water Life Science Advisors LP - MarketBeat
Quanterix Corp (QTRX) stock: A year of ups and downs - uspostnews.com
Emocog brings Quanterix’s ultra-sensitive Alzheimer’s blood test platform to Korea - koreabiomed.com
Russell Investments Group Ltd. Has $2.82 Million Stock Holdings in Quanterix Corporation $QTRX - MarketBeat
How Quanterix Corporation stock reacts to job market dataJuly 2025 Snapshot & Free High Accuracy Swing Entry Alerts - Newser
QTRX (Quanterix) EBITDA Margin % : -63.69% (As of Sep. 2025) - GuruFocus
Nothing is Better Than Quanterix Corp (QTRX) stock at the moment - Setenews
CEO Toloue Acquires 507 Of Quanterix Corp [QTRX] - TradingView — Track All Markets
Looking To Buy Quanterix Corp (QTRX)? Read This First - fostersleader.com
Is Quanterix Corporation stock supported by innovation pipelineMarket Activity Summary & Technical Entry and Exit Alerts - Newser
Quanterix (QTRX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Even after rising 26% this past week, Quanterix (NASDAQ:QTRX) shareholders are still down 83% over the past five years - simplywall.st
Ready to Jump After Recent Trade: Quanterix Corp (QTRX) - Setenews
CEO Toloue Acquires 1,238 Of Quanterix Corp [QTRX] - TradingView
Quanterix Corporation (QTRX) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Quanterix Corp Announces Board Changes - TradingView
Quanterix appoints new board members, names executive chair in leadership shift - Investing.com
Technical analysis overview for Quanterix Corporation stock2025 Fundamental Recap & AI Powered Trade Plan Recommendations - newser.com
Long term hold vs stop loss in Quanterix CorporationTrade Exit Report & Low Drawdown Trading Strategies - newser.com
It is Poised to be a Bull Market for Quanterix Corp (QTRX) - Setenews
Is Quanterix Corporation stock undervalued vs historical averagesGlobal Markets & High Accuracy Buy Signal Tips - newser.com
Quanterix Nears All-Stock Deal for Akoya Biosciences - MSN
Is Quanterix Corporation stock a buy in volatile marketsMarket Movers & Daily Volume Surge Trade Alerts - newser.com
Quanterix (NASDAQ: QTRX) Study Backs Dual GFAP/NfL Blood Test for MS Monitoring - Stock Titan
Can a trend reversal in Quanterix Corporation lead to recoveryWeekly Investment Recap & Weekly Return Optimization Plans - newser.com
Quanterix FY2025 EPS Estimate Reduced by Leerink Partnrs - Defense World
What to expect from Quanterix Corporation in the next 30 daysGap Down & Weekly Market Pulse Alerts - newser.com
Quanterix Corp Stock (QTRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Quanterix Corp Stock (QTRX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| WALT DAVID R | Director |
Jun 13 '25 |
Buy |
6.14 |
123,990 |
760,803 |
1,866,933 |
| WALT DAVID R | Director |
Jun 12 '25 |
Buy |
6.23 |
36,010 |
224,166 |
1,742,943 |
| Toloue Masoud | President & CEO |
Jun 09 '25 |
Buy |
5.42 |
45,900 |
248,723 |
518,922 |
| WALT DAVID R | Director |
Jun 06 '25 |
Buy |
5.43 |
131,869 |
716,576 |
1,628,802 |
| WALT DAVID R | Director |
Jun 09 '25 |
Buy |
5.34 |
78,131 |
417,220 |
1,706,933 |
| DONNELLY WILLIAM P | Director |
Jun 06 '25 |
Buy |
5.44 |
93,113 |
506,348 |
139,094 |
0.45%
0.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):